The Food and Drug Administration (FDA) has tentatively approved the generic versions of Lamivudine manufactured by Aurobindo Pharma Ltd. of Hyderabad, India and Ranbaxy of India. The generics are a version of Epivir manufactured by Glaxo Smith Kline. These approvals will allow the drugs to be used in developing countries as part of the United States AIDS initiatives which provide fast-track approval process opportunities for promising AIDS drugs. This drug is used in combination with other antiretrovirals.
India Manufactured AIDS drugs Approved
